Results 101 to 110 of about 15,817 (237)

Percutaneous versus open cannulation for mechanical support in patients with right ventricular failure after left ventricular assist device placement [PDF]

Exploration of Cardiology
Aim: Temporary right ventricular assist device (t-RVAD) is an option for those patients in right ventricular failure (RVF) after left ventricular assist device (LVAD) resistant to ionotropic therapy.
Amit Prasad, Anthony Kronfli, Nadia Assiaoui, Christoph Brehm, Behzad Soleimani   +4 more
doaj   +1 more source

Patients Experiencing Unsuccessful Defibrillation From Implantable Cardiac Devices Remain at Elevated Risk Despite Procedural Management

Journal of Cardiovascular Electrophysiology, Volume 37, Issue 6, Page 1356-1358, June 2026.
ABSTRACT Background Unsuccessful defibrillation therapy in patients with implantable cardiac defibrillators (ICDs) and ventricular tachytherapies may occur due to patient and/or device‐related factors; appropriate management strategies after failed defibrillation therapy have been incompletely described.
Nathaniel Christian‐Miller, Muazzum Shah, Kelly Arps, Amrish Deshmukh, Jackson Liang, Ryan Cunnane, Krit Jongnarangsin, Frank Pelosi, Hakan Oral, Michael Ghannam   +9 more
wiley   +1 more source

Successful management of mycotic visceral aneurysms in a LVAD patient and navigating LVAD postoperative challenges

This report presents a unique case of concurrent mycotic aneurysms in a 64-year-old male left ventricular assist device (LVAD) recipient. Initially admitted with odontogenic maxillary fungal sinusitis and fungemia, he later presented to our clinic with ...
Kendall Wermine, MD, Rusty Milhoan, MD, Mohammad Alqaim, MD, Salman Gohar, MD, Vivek Ramarathnam, MD, Bryan Youree, MD   +5 more
core   +1 more source

Pre-Implant Immune Status is Associated with Infection Risk After Left Ventricular Assist Device Implantation

Journal of Inflammation Research
Maja-Theresa Dieterlen,* Eva Katharina Messer,* Kristin Klaeske, Franz Sieg, Sandra Eifert, Josephina Haunschild, Khalil Jawad, Diyar Saeed, Alexey Dashkevich,* Michael Andrew Borger* University Clinic of Cardiac Surgery, Leipzig Heart ...
Dieterlen MT, Messer EK, Klaeske K, Sieg F, Eifert S, Haunschild J, Jawad K, Saeed D, Dashkevich A, Borger MA   +9 more
doaj  

The impact of Angiotensin II Type 1 Receptor antibodies on morbidity and mortality in Heart Mate II supported recipients

Biomedical Papers, 2016
Aims: One of the proposed limitations of left ventricular assist device (LVAD) therapy is high degree of sensitization. Apart from human leukocyte antigen (HLA), antibodies against Angiotensin II Type 1 Receptor (AT1R) have been associated with adverse ...
Marian Urban, Antonij Slavcev, Tomas Gazdic, Peter Ivak, Ivan Netuka   +4 more
doaj   +1 more source

CardioMEMSTM in LVAD Patients: A Case Series

The VAD Journal, 2016
Patients with a left ventricular assist device (LVAD) commonly encounter issues with volume status post-implant. Volume overload can result from incomplete compensation of left ventricular failure or from right ventricular failure. The CardioMEMS™ intracardiac hemodynamic monitoring device is an area of growing interest regarding the management of ...
Guglin, Maya, George, Bennet, Branam, Sarah, Hart, Amanda   +3 more
openaire   +2 more sources

Nocturnal Hypoxemic Burden Predicts Mortality in Patients Awaiting Heart Transplantation

Journal of Sleep Research, Volume 35, Issue 3, June 2026.
Trial design and results on hypoxemic burden in the context of heart transplantation. ABSTRACT Risk stratification for patients with end‐stage heart failure (HF) awaiting heart transplantation (HTX) is crucial. Sleep‐disordered breathing (SDB) is a prevalent comorbidity, yet the impact of its resultant hypoxemic burden remains unclear in this ...
Max Potratz, Tatevik Manukyan, René Schramm, Angelika Costard‐Jäckle, Uwe Fuchs, Michiel Morshuis, Sabina P. W. Guenther, Sebastian V. Rojas, Volker Rudolph, Jan F. Gummert, Henrik Fox   +10 more
wiley   +1 more source

Long-term left ventricular assist device support reinforces detrimental immunological effects

Frontiers in Immunology
IntroductionInfection is a common complication following left ventricular assist device (LVAD) implantation that increases the mortality in the post-implantation period. Immunological changes affecting dendritic cells (DCs), natural killer (NK) cells and
Maja-Theresa Dieterlen, Malina Sauskat, Kristin Klaeske, Eva Katharina Messer, Joanna Jozwiak-Nozdrzykowska, Alexey Dashkevich, Michael A. Borger, Sandra Eifert, Michal Nozdrzykowski   +8 more
doaj   +1 more source

Long‐Term Outcomes of Radiofrequency Atrioventricular Node Ablation in a Real‐World Population

Pacing and Clinical Electrophysiology, Volume 49, Issue 6, Page 698-706, June 2026.
ABSTRACT Background While interventional strategies have expanded the options for long term rhythm restoration, rate control continues to play a pivotal role in the treatment of atrial arrhythmias; however, pharmacologic strategies alone often fail in achieving effective rate control.
Vanessa Sciacca, Nora‐Kristin Brandt, Thomas Fink, Denise Guckel, Maximilian Mörsdorf, Yuri Bocchini, Martin Braun, Moneeb Khalaph, Karen Harutyunyan, Nadica Trajkovska, Philipp Lucas, Thomas Eitz, Maxim Didenko, Philipp Sommer, Christian Sohns   +14 more
wiley   +1 more source

LVAD in situs viscerum inversus totalis.

, 2011
LVAD in situs viscerum inversus ...
LUCIANI, GIOVANNI BATTISTA, FAGGIAN, Giuseppe, Giuseppe Faggian, Alberto Forni, Giovanni Battista Luciani, FORNI, ALBERTO   +5 more
core   +1 more source